|
1
|
Whittier X and Saag KG:
Glucocorticoid-induced Osteoporosis. Rheum Dis Clin North Am.
42:177–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buehring B, Viswanathan R, Binkley N and
Busse W: Glucocorticoid-induced osteoporosis: An update on effects
and management. J Allergy Clin Immunol. 132:1019–1030. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fukushima W, Fujioka M, Kubo T, Tamakoshi
A, Nagai M and Hirota Y: Nationwide epidemiologic survey of
idiopathic osteonecrosis of the femoral head. Clin Orthop Relat
Res. 468:2715–2724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Compston J: Management of
glucocorticoid-induced osteoporosis. Nat Rev Rheumatol. 6:82–88.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yun SI, Yoon HY, Jeong SY and Chung YS:
Glucocorticoid induces apoptosis of osteoblast cells through the
activation of glycogen synthase kinase 3beta. J Bone Miner Metab.
27:140–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li H, Qian W, Weng X, Wu Z, Li H, Zhuang
Q, Feng B and Bian Y: Glucocorticoid receptor and sequential P53
activation by dexamethasone mediates apoptosis and cell cycle
arrest of osteoblastic MC3T3-E1 cells. PLoS One. 7:e370302012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohnaka K, Tanabe M, Kawate H, Nawata H and
Takayanagi R: Glucocorticoid suppresses the canonical Wnt signal in
cultured human osteoblasts. Biochem Biophys Res Commun.
329:177–181. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Brien CA, Jia D, Plotkin LI, Bellido T,
Powers CC, Stewart SA, Manolagas SC and Weinstein RS:
Glucocorticoids act directly on osteoblasts and osteocytes to
induce their apoptosis and reduce bone formation and strength.
Endocrinology. 145:1835–1841. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao L, Cai G and Shi X: Beta-ecdysterone
induces osteogenic differentiation in mouse mesenchymal stem cells
and relieves osteoporosis. Biol Pharm Bull. 31:2245–2249. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cahlíková L, Macáková K, Chlebek J,
Host'álková A, Kulhánková A and Opletal L: Ecdysterone and its
activity on some degenerative diseases. Nat Prod Commun. 6:707–718.
2011.PubMed/NCBI
|
|
11
|
Syrov VN, Khushbaktova ZA and Nabiev AN:
An experimental study of the hepatoprotective properties of
phytoecdysteroids and nerobol in carbon tetrachloride-induced liver
lesion. Eksp Klin Farmakol. 55:61–65. 1992.(In Russian). PubMed/NCBI
|
|
12
|
Zou Y, Wang R, Guo H and Dong M:
Phytoestrogen β-ecdysterone protects PC12 cells against
MPP+−induced neurotoxicity in vitro: Involvement of
PI3K-Nrf2-regulated pathway. Toxicol Sci. 147:28–38. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan Z, Niu Y, Liang Y, Zhang X and Dong M:
β-Ecdysterone protects SH-SY5Y cells against
6-hydroxydopamine-induced apoptosis via mitochondria-dependent
mechanism: Involvement of p38MAPK-p53 signaling pathway. Neurotox
Res. 30:453–466. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Z and Klionsky DJ: Eaten alive: A
history of macroautophagy. Nat Cell Biol. 12:814–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang YH, Chen K, Li B, Chen JW, Zheng XF,
Wang YR, Jiang SD and Jiang LS: Estradiol inhibits osteoblast
apoptosis via promotion of autophagy through the ER-ERK-mTOR
pathway. Apoptosis. 18:1363–1375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia X, Kar R, Gluhak-Heinrich J, Yao W,
Lane NE, Bonewald LF, Biswas SK, Lo WK and Jiang JX:
Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res.
25:2479–2488. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Komori T: Regulation of osteoblast
differentiation by Runx2. Adv Exp Med Biol. 658:43–49. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choo MK, Yeo H and Zayzafoon M: NFATc1
mediates HDAC-dependent transcriptional repression of osteocalcin
expression during osteoblast differentiation. Bone. 45:579–589.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu FB, Wang JY, Zhang YL, Quan RF, Yue
ZS, Zeng LR, Zheng WJ, Hou Q, Yan SG and Hu YG: Curculigoside
regulates proliferation, differentiation, and pro-inflammatory
cytokines levels in dexamethasone-induced rat calvarial
osteoblasts. Int J Clin Exp Med. 8:12337–12346. 2015.PubMed/NCBI
|
|
22
|
Hamidouche Z, Haÿ E, Vaudin P, Charbord P,
Schüle R, Marie PJ and Fromigué O: FHL2 mediates
dexamethasone-induced mesenchymal cell differentiation into
osteoblasts by activating Wnt/beta-catenin signaling-dependent
Runx2 expression. FASEB J. 22:3813–3822. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Canu N, Tufi R, Serafino AL, Amadoro G,
Ciotti MT and Calissano P: Role of the autophagic-lysosomal system
on low potassium-induced apoptosis in cultured cerebellar granule
cells. J Neurochem. 92:1228–1242. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Conradie MM, de Wet H, Kotze DD, Burrin
JM, Hough FS and Hulley PA: Vanadate prevents
glucocorticoid-induced apoptosis of osteoblasts in vitro and
osteocytes in vivo. J Endocrinol. 195:229–240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo S and Rubinsztein DC: Apoptosis blocks
Beclin 1-dependent autophagosome synthesis: An effect rescued by
Bcl-xL. Cell Death Differ. 17:268–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qu X, Yu J, Bhagat G, Hibshoosh H, Troxel
A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G and
Levine B: Promotion of tumorigenesis by heterozygous disruption of
the beclin 1 autophagy gene. J Clin Invest. 112:1809–1820. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nollet M, Santucci-Darmanin S, Breuil V,
Al-Sahlanee R, Cros C, Topi M, Momier D, Samson M, Pagnotta S,
Cailleteau L, et al: Autophagy in osteoblasts is involved in
mineralization and bone homeostasis. Autophagy. 10:1965–1977. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai W, Jiang L, Lay YA, Chen H, Jin G,
Zhang H, Kot A, Ritchie RO, Lane NE and Yao W: Prevention of
glucocorticoid induced bone changes with beta-ecdysone. Bone.
74:48–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wander SA, Hennessy BT and Slingerland JM:
Next-generation mTOR inhibitors in clinical oncology: How pathway
complexity informs therapeutic strategy. J Clin Invest.
121:1231–1241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fiorini C, Menegazzi M, Padroni C, Dando
I, Dalla Pozza E, Gregorelli A, Costanzo C, Palmieri M and
Donadelli M: Autophagy induced by p53-reactivating molecules
protects pancreatic cancer cells from apoptosis. Apoptosis.
18:337–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pantovic A, Krstic A, Janjetovic K, Kocic
J, Harhaji-Trajkovic L, Bugarskib D and Trajkovica V: Coordinated
time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy
controls osteogenic differentiation of human mesenchymal stem
cellsc. Bone. 52:524–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
